본문 바로가기

내분비내과/이상지질혈증

Clinical risk factors for stroke, TIA, and systemic embolism in the CHA2DS2-VASc score

728x90
반응형

Clinical risk factors for stroke, transient ischemic attack, and systemic embolism in the CHA2DS2-VASc score

(A) The risk factor-based approach expressed as a point based scoring system, with the acronym CHA2DS2-VASc

(NOTE: maximum score is 9 since age may contribute 0, 1, or 2 points)

CHA2DS2-VASc risk factor

Points

Congestive heart failure

Signs/symptoms of heart failure or objective evidence of reduced left-ventricular ejection fraction

+1

Hypertension

Resting blood pressure >140/90 mmHg on at least two occasions or current antihypertensive treatment

+1

Age 75 years or older

+2

Diabetes mellitus

Fasting glucose >125 mg/dL (7 mmol/L) or treatment with oral hypoglycaemic agent and/or insulin

+1

Previous stroke, transient ischaemic attack, or thromboembolism

+2

Vascular disease

Previous myocardial infarction, peripheral artery disease, or aortic plaque

+1

Age 65-74 years

+1

Sex category (female)

+1

 

(B) Adjusted stroke rate according to CHA2DS2-VASc score

CHA2DS2-VASc score

Patients

(n = 73,538)

Stroke and thromboembolism event rate at one-year follow-up (%)

0

6369

0.78

1

8203

2.01

2

12,771

3.71

3

17,371

5.92

4

13,887

9.27

5

8942

15.26

6

4244

19.74

7

1420

21.50

8

285

22.38

9

46

23.64

CHA2DS2-VASc: Congestive heart failure, Hypertension, Age (≥75) (doubled), Diabetes, Stroke (doubled), Vascular disease, Age (65-74), Sex.


Part A from: Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18(11):1609-1678. By permission of Oxford University Press on behalf of the European Society of Cardiology. Copyright © 2016 Oxford University Press. Available at: www.escardio.org/.

REF. UpToDate 2019.08.25

728x90
반응형